Hydrophilic polysaccharide-based pharmaceutical perparation for external use
AssigneeShimizu Chemical Corporation
InventorHideki Shimizu
Life of this patent
Estimating the term…
Abstract
The present invention provides a pharmaceutical preparation for the treatment of a wound consisting essentially of 200-mesh or finer powder of one or more hydrophilic polysaccharides selected from the group consisting of glucomannan and guar gum. Also provided is a pharmaceutical preparation for prophylaxis and treatment of chapped skin consisting essentially of an aqueous solution of one or more hydrophilic polysaccharides selected from the group consisting of glucomannan and guar gum.
Claims16
A pharmaceutical preparation for external use consisting essentially of one or more powder form hydrophilic polysaccharides and one or more local anesthetics and/or antimicrobials.
A pharmaceutical preparation for external use consisting essentially of an aqueous solution of one or more hydrophilic polysaccharides and one or more preservatives and/or keratin softening preparations.
A method of treatment of a skin wound of a human comprising spreading over the opening of the wound a therapeutically effective amount of a pharmaceutical preparation consisting essentially of one or more powder form hydrophilic polysaccharides selected from the group consisting of glucomannan and guar gum.
A method of prophylaxis and treatment of chapped skin of a human comprising applying to the skin area to be protected against or treated for chapping a prophylactically or therapeutically effective amount of a pharmaceutical preparation consisting essentially of an aqueous solution obtainable by dissolving in water one or more hydrophilic polysaccharides selected from the group consisting of glucomannan and guar gum at a total concentration of 0.1 to 10.0 W/V %.
Dependencies are inferred from the claim text.